These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
445 related articles for article (PubMed ID: 23402794)
1. Botulinum toxin A increases analgesic effects of morphine, counters development of morphine tolerance and modulates glia activation and μ opioid receptor expression in neuropathic mice. Vacca V; Marinelli S; Luvisetto S; Pavone F Brain Behav Immun; 2013 Aug; 32():40-50. PubMed ID: 23402794 [TBL] [Abstract][Full Text] [Related]
2. Botulinum neurotoxin A enhances the analgesic effects on inflammatory pain and antagonizes tolerance induced by morphine in mice. Vacca V; Marinelli S; Eleuteri C; Luvisetto S; Pavone F Brain Behav Immun; 2012 Mar; 26(3):489-99. PubMed ID: 22281280 [TBL] [Abstract][Full Text] [Related]
3. Attenuation of morphine tolerance by minocycline and pentoxifylline in naive and neuropathic mice. Mika J; Wawrzczak-Bargiela A; Osikowicz M; Makuch W; Przewlocka B Brain Behav Immun; 2009 Jan; 23(1):75-84. PubMed ID: 18684397 [TBL] [Abstract][Full Text] [Related]
4. Botulinum neurotoxin type A counteracts neuropathic pain and facilitates functional recovery after peripheral nerve injury in animal models. Marinelli S; Luvisetto S; Cobianchi S; Makuch W; Obara I; Mezzaroma E; Caruso M; Straface E; Przewlocka B; Pavone F Neuroscience; 2010 Nov; 171(1):316-28. PubMed ID: 20826198 [TBL] [Abstract][Full Text] [Related]
5. The analgesic effect on neuropathic pain of retrogradely transported botulinum neurotoxin A involves Schwann cells and astrocytes. Marinelli S; Vacca V; Ricordy R; Uggenti C; Tata AM; Luvisetto S; Pavone F PLoS One; 2012; 7(10):e47977. PubMed ID: 23110146 [TBL] [Abstract][Full Text] [Related]
6. Regulation of spinal neuroimmune responses by prolonged morphine treatment in a rat model of cancer induced bone pain. Cao F; Gao F; Xu AJ; Chen ZJ; Chen SS; Yang H; Yu HH; Mei W; Liu XJ; Xiao XP; Yang SB; Tian XB; Wang XR; Tian YK Brain Res; 2010 Apr; 1326():162-73. PubMed ID: 20176002 [TBL] [Abstract][Full Text] [Related]
7. Lipoxin A4 analog attenuates morphine antinociceptive tolerance, withdrawal-induced hyperalgesia, and glial reaction and cytokine expression in the spinal cord of rat. Jin H; Li YH; Xu JS; Guo GQ; Chen DL; Bo Y Neuroscience; 2012 Apr; 208():1-10. PubMed ID: 22366510 [TBL] [Abstract][Full Text] [Related]
8. mu-Opioid receptor internalization-dependent and -independent mechanisms of the development of tolerance to mu-opioid receptor agonists: Comparison between etorphine and morphine. Narita M; Suzuki M; Narita M; Niikura K; Nakamura A; Miyatake M; Yajima Y; Suzuki T Neuroscience; 2006; 138(2):609-19. PubMed ID: 16417975 [TBL] [Abstract][Full Text] [Related]
9. Low-Dose Cannabinoid Type 2 Receptor Agonist Attenuates Tolerance to Repeated Morphine Administration via Regulating μ-Opioid Receptor Expression in Walker 256 Tumor-Bearing Rats. Zhang M; Wang K; Ma M; Tian S; Wei N; Wang G Anesth Analg; 2016 Apr; 122(4):1031-7. PubMed ID: 26720619 [TBL] [Abstract][Full Text] [Related]
10. Botulinum Toxin B Affects Neuropathic Pain but Not Functional Recovery after Peripheral Nerve Injury in a Mouse Model. Finocchiaro A; Marinelli S; De Angelis F; Vacca V; Luvisetto S; Pavone F Toxins (Basel); 2018 Mar; 10(3):. PubMed ID: 29562640 [TBL] [Abstract][Full Text] [Related]
11. Ethosuximide reduces allodynia and hyperalgesia and potentiates morphine effects in the chronic constriction injury model of neuropathic pain. Hamidi GA; Ramezani MH; Arani MN; Talaei SA; Mesdaghinia A; Banafshe HR Eur J Pharmacol; 2012 Jan; 674(2-3):260-4. PubMed ID: 22134003 [TBL] [Abstract][Full Text] [Related]
12. The effect of botulinum neurotoxin A on sciatic nerve injury-induced neuroimmunological changes in rat dorsal root ganglia and spinal cord. Mika J; Rojewska E; Makuch W; Korostynski M; Luvisetto S; Marinelli S; Pavone F; Przewlocka B Neuroscience; 2011 Feb; 175():358-66. PubMed ID: 21111791 [TBL] [Abstract][Full Text] [Related]
13. Ultralow dose fentanyl prevents development of chronic neuropathic pain in rats. Wala EP; Holtman JR; Sloan PA J Opioid Manag; 2013; 9(2):85-96. PubMed ID: 23709318 [TBL] [Abstract][Full Text] [Related]
14. Participation of pro- and anti-nociceptive interleukins in botulinum toxin A-induced analgesia in a rat model of neuropathic pain. Zychowska M; Rojewska E; Makuch W; Luvisetto S; Pavone F; Marinelli S; Przewlocka B; Mika J Eur J Pharmacol; 2016 Nov; 791():377-388. PubMed ID: 27619001 [TBL] [Abstract][Full Text] [Related]
15. Effect of morphine on deep dorsal horn projection neurons depends on spinal GABAergic and glycinergic tone: implications for reduced opioid effect in neuropathic pain. Chen YP; Chen SR; Pan HL J Pharmacol Exp Ther; 2005 Nov; 315(2):696-703. PubMed ID: 16033910 [TBL] [Abstract][Full Text] [Related]
16. Efficacy of propentofylline, a glial modulating agent, on existing mechanical allodynia following peripheral nerve injury. Tawfik VL; Nutile-McMenemy N; Lacroix-Fralish ML; Deleo JA Brain Behav Immun; 2007 Feb; 21(2):238-46. PubMed ID: 16949251 [TBL] [Abstract][Full Text] [Related]
17. Direct evidence for spinal cord microglia in the development of a neuropathic pain-like state in mice. Narita M; Yoshida T; Nakajima M; Narita M; Miyatake M; Takagi T; Yajima Y; Suzuki T J Neurochem; 2006 Jun; 97(5):1337-48. PubMed ID: 16606373 [TBL] [Abstract][Full Text] [Related]
18. The multitarget opioid ligand LP1's effects in persistent pain and in primary cell neuronal cultures. Parenti C; Turnaturi R; Aricò G; Gramowski-Voss A; Schroeder OH; Marrazzo A; Prezzavento O; Ronsisvalle S; Scoto GM; Ronsisvalle G; Pasquinucci L Neuropharmacology; 2013 Aug; 71():70-82. PubMed ID: 23541722 [TBL] [Abstract][Full Text] [Related]
19. The plasticity of the association between mu-opioid receptor and glutamate ionotropic receptor N in opioid analgesic tolerance and neuropathic pain. Sánchez-Blázquez P; Rodríguez-Muñoz M; Berrocoso E; Garzón J Eur J Pharmacol; 2013 Sep; 716(1-3):94-105. PubMed ID: 23499699 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of microglial P2X4 receptors attenuates morphine tolerance, Iba1, GFAP and mu opioid receptor protein expression while enhancing perivascular microglial ED2. Horvath RJ; Romero-Sandoval AE; De Leo JA Pain; 2010 Sep; 150(3):401-413. PubMed ID: 20573450 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]